Page last updated: 2024-09-04

ertapenem and Cross Infection

ertapenem has been researched along with Cross Infection in 49 studies

*Cross Infection: Any infection which a patient contracts in a health-care institution. [MeSH]

Research

Studies (49)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	13 (26.53)	29.6817
2010's	33 (67.35)	24.3611
2020's	3 (6.12)	2.80

Authors

Authors	Studies
Cornaglia, G; Koncan, R; Mazzariol, A; Roelofsen, E; Voss, A	1
Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L	1
Hsueh, PR; Huang, YT; Liao, CH; Lin, HY; Liu, CY; Yen, LC	1
Herrera, ML; Jorgensen, JH; Lewis, JS; Prakash, V; Wickes, BL	1
Chen, H; Chen, M; Sun, H; Wang, H; Xu, Y; Yang, Q	1
Badal, RE; Baquero, F; Bouchillon, SK; Cantón, R; Hawser, SP; Hoban, DJ	1
Bernabeu, S; Nordmann, P; Poirel, L; Revathi, G	1
Ahmadi, A; Shahin, M	1
Bhattacharjee, A; Chakravarty, A; Chanda, DD; Paul, D	1
Blackmore, TK; Bloomfield, MG; Studd, RC; Wilson, AD	1
Kim, HS; Kim, HY; Kim, YK; Lee, J; Lee, JA; Lee, SS; Seo, YB; Song, W; Uh, Y	1
Cheng, A; Chuang, YC; Sheng, WH; Wang, JT; Yang, JJ	1
Badal, R; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S	1
Perez, LRR	1
Aznar, J; Barrón-Adúriz, R; Calvo, J; Cantón, R; Castillo, FJ; Cercenado, E; Cisterna, R; González-Romo, F; López-Hontangas, JL; López-Mendoza, D; Loza, E; Molloy, B; Suárez-Barrenechea, AI; Tubau, F	1
Decloedt, EH; Dramowski, A; Finlayson, H; Koopmans, LR; Whitelaw, A	1
Bou, G; Castelo-Corral, L; Gutiérrez-Urbón, JM; Llinares, P; López-Calviño, B; Molina, F; Sousa, D	1
Badal, RE; Cao, B; Chen, M; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Y; Hu, Z; Huang, W; Kong, H; Liao, K; Lu, J; Ni, Y; Shao, H; Shen, D; Su, J; Sun, Z; Wang, H; Wang, Y; Wu, A; Xu, Y; Yang, Q; Ye, H; Yu, Y; Zhang, H; Zhang, S	1
Chang, CL; Chang, KK; Huang, YC; Lu, CM; Su, LH; Tai, FT	1
Badal, RE; Biedenbach, DJ; Bouchillon, SK; Hackel, M; Hoban, DJ; Nga, TT; Phuong, DM; Phuong, NT; Phuong, TT	1
Ahn, C; Doi, Y; Hu, F; O'Hara, JA; Rivera, JI; Syed, A	1
Chen, CH; Chen, JB; Chiu, CH; Chuang, FR; Lee, CT; Liu, HT; Wu, CH; Yang, CC	1
Garritson, S; Lee, S; Lin, M; Liu, C; Nichols, A; Prasad, P	1
Cipolla, A; D'Abramo, A; D'Agostino, C; Gizzi, F; Iannetta, M; Mascellino, MT; Mastroianni, CM; Oliva, A; Russo, G; Tierno, F; Trinchieri, V; Vullo, V	1
Badal, RE; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S	1
Chongtrakool, P; Diraphat, P; Malathum, K; Pornsinchai, P; Siripanichgon, K	1
Cachero, A; Castellote, J; Dueñas, E; Girbau, A; Grau, I	1
Berrio, I; Castro, B; Maldonado, N; Manjarrés, M; Robledo, C; Robledo, J	1
Cipolla, A; D'Abramo, A; De Angelis, M; Favaro, M; Ferretti, G; Gizzi, F; Iannetta, M; Mascellino, MT; Mastroianni, CM; Oliva, A; Russo, G; Vullo, V	1
Manzano-García, M; Márquez-Saavedra, E	1
Alp, E; Badal, R; Gulay, Z; Koksal, I; Korten, V; Lob, S; Mete, B; Mulazimoglu, L; Oguz, VA; Tabak, F; Unal, S; Yilmaz, G; Zarakolu, P	1
Angeletti, S; Ciotti, M; Dolfa, C; Favalli, C; Sakarikou, C	1
Abrahamian, FM; Deblieux, PM; Emerman, CL; Kollef, MH; Kupersmith, E; Leeper, KV; Paterson, DL; Shorr, AF	1
Dal-Paz, K; Lima, AL; Oliveira, PR; Paula, AP; Rossi, F; Zumiotti, AV	1
Ermertcan, S; Hosgor-Limoncu, M; Tasli, H; Yurtman, AN	1
Bonomo, RA; Casiano-Colón, AE; Depasquale, JM; Endimiani, A; Fiorella, PD; Forero, S; Hujer, AM; Kitchel, B; Perez, F; Pickens, N; Roberts-Pollack, D; Tenover, FC	1
Ferraro, MJ; Hooper, DC; Hyle, EP; Lee, H; Silver, M	1
Cai, J; Liu, J; Wu, D	1
Chung, JK; Dong, F; Graber, CJ; Hutchings, C; Lee, W; Tran, T	1
Gastal, SL; Goldani, LZ; Gorniak Lovatto, C; Jacoby, T; Konkewicz, L; Kuplich, NM; Lisboa, T; Nagel, FM; Pires dos Santos, R; Pires Machado, D; Pires, MR	1
Cook, PP; Gooch, M; Rizzo, S	1
Abreu-Lanfranco, O; Bhargava, P; Bheemreddy, S; Blunden, C; Carmeli, Y; Chopra, T; Chugh, N; Collins, VL; Eiseler, S; Hayakawa, K; Kaye, KS; Lephart, PR; Marchaim, D; Memon, BI; Moshos, J; Munoz-Price, LS; Pogue, JM; Shallal, A; Sunkara, B	1
Cai, Y; Kwa, AL; Lee, W; Tan, TT; Tan, TY; Tang, S; Teo, J	1
Hsueh, PR	1
Isaacs, RD; Shah, PM	1
Karpov, OI; Strekachev, AIu; Zaĭtsev, AA	1
Brink, AJ; Feldman, C; Grolman, DC; Muckart, D; Pretorius, J; Richards, GA; Senekal, M; Sieling, W	1
Adeyi, B; DiNubile, MJ; Friedland, IR; Ginanni, JA; McCarroll, KA; Stratchounski, LS; Wood, CA; Woods, GL; Yakovlev, SV	1
Joseph, J; Rodvold, KA	1

Reviews

5 review(s) available for ertapenem and Cross Infection

Article	Year
Health care-associated pneumonia: identification and initial management in the ED. The American journal of emergency medicine, 2008, Volume: 26, Issue:6 Suppl Topics: Acetamides; Age Distribution; Aged; Aged, 80 and over; Anti-Infective Agents; beta-Lactams; Cephalosporins; Cross Infection; Emergency Treatment; Ertapenem; Female; Humans; Length of Stay; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Oxazolidinones; Patient Care Team; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Practice Guidelines as Topic; Respiration, Artificial; Risk Factors; Severity of Illness Index; Tigecycline	2008
Ertapenem, the first of a new group of carbapenems. The Journal of antimicrobial chemotherapy, 2003, Volume: 52, Issue:4 Topics: Animals; beta-Lactams; Carbapenems; Clinical Trials as Topic; Cross Infection; Ertapenem; Humans; Lactams	2003
[New approaches to antibacterial therapy of infections in the surgical practice]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2003, Volume: 48, Issue:5 Topics: Abdominal Abscess; Aza Compounds; Bacterial Infections; beta-Lactams; Community-Acquired Infections; Cross Infection; Ertapenem; Fluoroquinolones; Humans; Lactams; Moxifloxacin; Quinolines; Randomized Controlled Trials as Topic; Surgical Wound Infection	2003
Appropriate use of the carbapenems. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2004, Volume: 94, Issue:10 Pt 2 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Cilastatin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Ertapenem; Humans; Imipenem; Lactams; Meropenem; Patient Selection; Pneumonia, Bacterial; Practice Patterns, Physicians'; Protease Inhibitors; South Africa; Surgical Wound Infection; Thienamycins; Urinary Tract Infections	2004
The role of carbapenems in the treatment of severe nosocomial respiratory tract infections. Expert opinion on pharmacotherapy, 2008, Volume: 9, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cross Infection; Doripenem; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Meropenem; Patient Selection; Pneumonia, Bacterial; Respiratory Tract Infections; Severity of Illness Index; Thienamycins; Treatment Outcome	2008

Trials

2 trial(s) available for ertapenem and Cross Infection

Article	Year
Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli. BMC infectious diseases, 2017, 06-07, Volume: 17, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Cross Infection; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Genotype; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Republic of Korea; Tazobactam; Urinary Tract Infections	2017
Ertapenem versus cefepime for initial empirical treatment of pneumonia acquired in skilled-care facilities or in hospitals outside the intensive care unit. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2006, Volume: 25, Issue:10 Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cefepime; Cephalosporins; Cross Infection; Double-Blind Method; Drug Administration Schedule; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Intensive Care Units; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Skilled Nursing Facilities	2006

Article

Year

Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli.

BMC infectious diseases, 2017, 06-07, Volume: 17, Issue:1

Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Cross Infection; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Genotype; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Republic of Korea; Tazobactam; Urinary Tract Infections

2017

Ertapenem versus cefepime for initial empirical treatment of pneumonia acquired in skilled-care facilities or in hospitals outside the intensive care unit.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2006, Volume: 25, Issue:10

Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cefepime; Cephalosporins; Cross Infection; Double-Blind Method; Drug Administration Schedule; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Intensive Care Units; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Skilled Nursing Facilities

2006

Other Studies

42 other study(ies) available for ertapenem and Cross Infection

Article	Year
Detection of a new SHV-type extended-spectrum beta-lactamase, SHV-31, in a Klebsiella pneumoniae strain causing a large nosocomial outbreak in The Netherlands. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Netherlands; Plasmids	2007
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8 Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey	2008
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9 Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; Blood; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Taiwan	2008
Oral and parenteral therapeutic options for outpatient urinary infections caused by enterobacteriaceae producing CTX-M extended-spectrum beta-lactamases. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3 Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefdinir; Cephalosporins; Cross Infection; Enterobacteriaceae; Ertapenem; Escherichia coli; Fosfomycin; Humans; Infusions, Parenteral; Microbial Sensitivity Tests; Outpatients; Urinary Tract Infections	2009
Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospital-based surveillance studies in China. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Genotype; Integrons; Microbial Sensitivity Tests; Phenotype; Population Surveillance; Porins; Reverse Transcriptase Polymerase Chain Reaction	2010
Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Antimicrob Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:7 Topics: Abdomen; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae	2010
Detection of NDM-1-producing Klebsiella pneumoniae in Kenya. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:2 Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Kenya; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction	2011
Molecular characterization of NDM-1-producing Pseudomonas aeruginosa isolates from hospitalized patients in Iran. Annals of clinical microbiology and antimicrobials, 2021, Nov-03, Volume: 20, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Inpatients; Iran; Microbial Sensitivity Tests; Molecular Typing; Polymerase Chain Reaction; Pseudomonas aeruginosa	2021
An insight into analysis and elimination of plasmids encoding metallo-β-lactamases in Pseudomonas aeruginosa. Journal of global antimicrobial resistance, 2020, Volume: 21 Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Cefotaxime; Cross Infection; DNA Copy Number Variations; Drug Resistance, Multiple, Bacterial; Ertapenem; Gene Expression Regulation, Bacterial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections; Sodium Dodecyl Sulfate; Suppuration; Urine	2020
Highly effective prophylaxis with ertapenem for transrectal ultrasound-guided prostate biopsy: effects on overall antibiotic use and inpatient hospital exposure. The Journal of hospital infection, 2020, Volume: 106, Issue:3 Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy; Cross Infection; Ertapenem; Hospitals; Humans; Injections, Intramuscular; Inpatients; Male; Middle Aged; Prostate; Prostatic Neoplasms; Rectum; Sepsis; Ultrasonography, Interventional	2020
Impact of broad-spectrum antimicrobial treatment on the ecology of intestinal flora. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2018, Volume: 51, Issue:5 Topics: Acinetobacter baumannii; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; beta-Lactams; Cephalosporins; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Ertapenem; Feces; Female; Fluoroquinolones; Gastrointestinal Microbiome; Humans; Male; Microbial Viability; Middle Aged; Moxifloxacin; Pseudomonas aeruginosa; Taiwan	2018
Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients. BMC infectious diseases, 2017, 12-18, Volume: 17, Issue:1 Topics: Abdomen; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; China; Community-Acquired Infections; Cross Infection; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Incidence; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests	2017
From Dusk to Dawn: Understanding the Impact of Ertapenem Resistance Mechanisms on the In Vitro Potency of Other Drugs Among Enterobacter cloacae Complex Isolates. Infection control and hospital epidemiology, 2018, Volume: 39, Issue:4 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Brazil; Carbapenem-Resistant Enterobacteriaceae; Cross Infection; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Humans; Infection Control; Microbial Sensitivity Tests	2018
Antimicrobial susceptibility trends and evolution of isolates with extended spectrum β-lactamases among Gram-negative organisms recovered during the SMART study in Spain (2011-2015). Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2018, Volume: 31, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Drug Combinations; Ertapenem; Escherichia coli; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Spain	2018
Paediatric antimicrobial use at a South African hospital. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2018, Volume: 74 Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Child; Community-Acquired Infections; Cross Infection; Ertapenem; Female; Hospitalization; Hospitals; Humans; Infant; Intensive Care Units, Pediatric; Male; Medical Overuse; Meropenem; Pediatrics; Pharmacies; South Africa	2018
Impact of ertapenem use on Pseudomonas aeruginosa and Acinetobacter baumannii imipenem susceptibility rates: collateral damage or positive effect on hospital ecology? The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:8 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Ciprofloxacin; Cross Infection; Drug Utilization; Ecosystem; Ertapenem; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Retrospective Studies; Selection, Genetic; Tertiary Care Centers	2013
A 10 year surveillance for antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae in community- and hospital-associated intra-abdominal infections in China. Journal of medical microbiology, 2013, Volume: 62, Issue:Pt 9 Topics: Anti-Bacterial Agents; beta-Lactams; China; Community-Acquired Infections; Cross Infection; Ertapenem; Escherichia coli; Humans; Imipenem; Intraabdominal Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Prevalence	2013
Outbreak of ertapenem-resistant Enterobacter cloacae urinary tract infections due to a contaminated ureteroscope. The Journal of hospital infection, 2013, Volume: 85, Issue:2 Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Cluster Analysis; Cross Infection; Disease Outbreaks; Disinfection; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Female; Genes, Bacterial; Genotype; Hospitals, Teaching; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Polymerase Chain Reaction; Sequence Analysis, DNA; Taiwan; Ureteroscopes; Urinary Tract Infections	2013
Antimicrobial susceptibility and extended-spectrum beta-lactamase rates in aerobic gram-negative bacteria causing intra-abdominal infections in Vietnam: report from the Study for Monitoring Antimicrobial Resistance Trends (SMART 2009-2011). Diagnostic microbiology and infectious disease, 2014, Volume: 79, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intraabdominal Infections; Microbial Sensitivity Tests; Vietnam	2014
Microbiological features of KPC-producing Enterobacter isolates identified in a U.S. hospital system. Diagnostic microbiology and infectious disease, 2014, Volume: 80, Issue:2 Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Enterobacter cloacae; Enterobacteriaceae Infections; Ertapenem; Female; Genotype; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Pennsylvania; Plasmids; Young Adult	2014
Nosocomial extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteremia in hemodialysis patients and the implications for antibiotic therapy. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2014, Volume: 28 Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Cephalosporins; Cross Infection; Ertapenem; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Treatment Outcome	2014
Ertapenem Prophylaxis Associated With an Increased Risk of Clostridium difficile Infection Among Surgical Patients. Infection control and hospital epidemiology, 2015, Volume: 36, Issue:11 Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Case-Control Studies; Clostridioides difficile; Clostridium Infections; Cross Infection; Ertapenem; Female; Hospitalization; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Postoperative Complications; Retrospective Studies; Risk Factors	2015
Bactericidal and synergistic activity of double-carbapenem regimen for infections caused by carbapenemase-producing Klebsiella pneumoniae. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2016, Volume: 22, Issue:2 Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ertapenem; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Sepsis; Thienamycins	2016
Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1 Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; China; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Gene Expression; Humans; Imipenem; Intraabdominal Infections; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam	2016
EMERGENCY ROOM: AN UNRECOGNIZED SOURCE OF EXTENDED-SPECTRUM β-LACTAMASE PRODUCING ESCHERICHIA COLI AND KLEBSIELLA PNEUMONIAE. The Southeast Asian journal of tropical medicine and public health, 2015, Volume: 46, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Emergency Service, Hospital; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Plasmids; Thailand; Thienamycins; Young Adult	2015
Ertapenem failure as therapy for nosocomial spontaneous bacterial peritonitis. Gastroenterologia y hepatologia, 2016, Volume: 39, Issue:10 Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Substitution; Ertapenem; Escherichia coli; Escherichia coli Infections; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hepatorenal Syndrome; Humans; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Male; Middle Aged; Peritonitis; Postoperative Complications; Treatment Failure	2016
Ertapenem resistance in 2 tertiary-care hospitals: Microbiology, epidemiology, and risk factors. Enfermedades infecciosas y microbiologia clinica, 2017, Volume: 35, Issue:8 Topics: Aged; Antimicrobial Stewardship; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Cefepime; Colombia; Cross Infection; Diagnosis-Related Groups; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Logistic Models; Male; Middle Aged; Retrospective Studies; Risk Factors; Tertiary Care Centers	2017
Severe Bloodstream Infection due to KPC-Producer E coli in a Renal Transplant Recipient Treated With the Double-Carbapenem Regimen and Analysis of In Vitro Synergy Testing: A Case Report. Medicine, 2016, Volume: 95, Issue:7 Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Drug Synergism; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Kidney Transplantation; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Middle Aged; Surgical Wound Infection; Thienamycins	2016
[Adequacy of treatment with ertapenem according to the criterion approved for the infection´s commission of a specialty hospital]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2016, Volume: 29, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Ertapenem; Female; Guideline Adherence; Hospitals; Humans; Inappropriate Prescribing; Internal Medicine; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Urinary Tract Infections; Young Adult	2016
Epidemiology and susceptibility of pathogens from SMART 2011-12 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections. The Journal of antimicrobial chemotherapy, 2017, 05-01, Volume: 72, Issue:5 Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefoxitin; Community-Acquired Infections; Cross Infection; Enterobacteriaceae; Ertapenem; Escherichia coli; Humans; Imipenem; Intensive Care Units; Intraabdominal Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Turkey; Urinary Tract Infections	2017
Rapid detection of carbapenemase-producing Klebsiella pneumoniae strains derived from blood cultures by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS). BMC microbiology, 2017, 03-08, Volume: 17, Issue:1 Topics: Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Blood Culture; Cell Culture Techniques; Cross Infection; Enterobacteriaceae; Ertapenem; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Laboratories; Proteomics; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors	2017
The impact of ertapenem use on the susceptibility of Pseudomonas aeruginosa to imipenem: a hospital case study. Infection control and hospital epidemiology, 2009, Volume: 30, Issue:5 Topics: Academic Medical Centers; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Brazil; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Ertapenem; Humans; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2009
Activity of amikacin, ertapenem, ciprofloxacin and levofloxacin alone and in combination against resistant nosocomial pathogens by time-kill. The West Indian medical journal, 2008, Volume: 57, Issue:2 Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Cross Infection; Drug Synergism; Drug Therapy, Combination; Ertapenem; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin	2008
Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system. The Journal of antimicrobial chemotherapy, 2009, Volume: 64, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Cluster Analysis; Cross Infection; Disease Outbreaks; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Ertapenem; Female; Florida; Hospitals; Humans; Immunoblotting; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Polymerase Chain Reaction; Sequence Analysis, DNA	2009
Ertapenem-resistant Enterobacteriaceae: risk factors for acquisition and outcomes. Infection control and hospital epidemiology, 2010, Volume: 31, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Boston; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Equipment Contamination; Ertapenem; Female; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Treatment Outcome; Urban Population; Young Adult	2010
Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae. Southern medical journal, 2011, Volume: 104, Issue:2 Topics: Age Factors; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Case-Control Studies; Chi-Square Distribution; Confidence Intervals; Cross Infection; Drug Resistance, Bacterial; Ertapenem; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Logistic Models; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Odds Ratio; Risk Factors; Thienamycins	2011
Changes in antibiotic usage and susceptibility in nosocomial Enterobacteriaceae and Pseudomonas isolates following the introduction of ertapenem to hospital formulary. Epidemiology and infection, 2012, Volume: 140, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactams; Cross Infection; Drug Prescriptions; Drug Resistance, Bacterial; Enterobacteriaceae; Ertapenem; Humans; Pseudomonas; Regression Analysis	2012
Hand hygiene, and not ertapenem use, contributed to reduction of carbapenem-resistant Pseudomonas aeruginosa rates. Infection control and hospital epidemiology, 2011, Volume: 32, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Carbapenems; Cross Infection; Ertapenem; Hand Disinfection; Hospitals, University; Humans; Incidence; Pseudomonas aeruginosa; Pseudomonas Infections; Regression Analysis	2011
Reduction in fluoroquinolone use following introduction of ertapenem into a hospital formulary is associated with improvement in susceptibility of Pseudomonas aeruginosa to group 2 carbapenems: a 10-year study. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:12 Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Ertapenem; Fluoroquinolones; Formularies, Hospital as Topic; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; North Carolina; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies	2011
Efficacy of ertapenem for treatment of bloodstream infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:4 Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cohort Studies; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome	2012
Risk factors, molecular epidemiology and outcomes of ertapenem-resistant, carbapenem-susceptible Enterobacteriaceae: a case-case-control study. PloS one, 2012, Volume: 7, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Case-Control Studies; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Logistic Models; Male; Middle Aged; Molecular Epidemiology; Multivariate Analysis; Risk Factors; Singapore; Treatment Outcome; Young Adult	2012
Study for Monitoring Antimicrobial Resistance Trends (SMART) in the Asia-Pacific region, 2002-2010. International journal of antimicrobial agents, 2012, Volume: 40 Suppl Topics: Anti-Bacterial Agents; Asia; Australasia; beta-Lactams; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Global Health; Humans; Microbial Sensitivity Tests	2012